TY - JOUR
T1 - Toward precision medicine
T2 - circadian rhythm of blood pressure and chronotherapy for hypertension - 2021 NHLBI workshop report
AU - Gumz, Michelle L.
AU - Shimbo, Daichi
AU - Abdalla, Marwah
AU - Balijepalli, Ravi C.
AU - Benedict, Christian
AU - Chen, Yabing
AU - Earnest, David J.
AU - Gamble, Karen L.
AU - Garrison, Scott R.
AU - Gong, Ming C.
AU - Hogenesch, John B.
AU - Hong, Yuling
AU - Ivy, Jessica R.
AU - Joe, Bina
AU - Laposky, Aaron D.
AU - Liang, Mingyu
AU - MacLaughlin, Eric J.
AU - Martino, Tami A.
AU - Pollock, David M.
AU - Redline, Susan
AU - Rogers, Amy
AU - Rudic, R. Dan
AU - Schernhammer, Eva S.
AU - Stergiou, George S.
AU - St-Onge, Marie-Pierre
AU - Wang, Xiaoling
AU - Wright, Jacqueline
AU - Oh, Young S.
N1 - Copyright:
© 2022 American Heart Association, Inc.
PY - 2023/3
Y1 - 2023/3
N2 - Healthy individuals exhibit blood pressure variation over a 24-hour period with higher blood pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of the blood pressure circadian rhythm has been linked to adverse health outcomes, for example, cardiovascular disease, dementia, and chronic kidney disease. However, the current diagnostic and therapeutic approaches lack sufficient attention to the circadian rhythmicity of blood pressure. Sleep patterns, hormone release, eating habits, digestion, body temperature, renal and cardiovascular function, and other important host functions as well as gut microbiota exhibit circadian rhythms, and influence circadian rhythms of blood pressure. Potential benefits of nonpharmacologic interventions such as meal timing, and pharmacologic chronotherapeutic interventions, such as the bedtime administration of antihypertensive medications, have recently been suggested in some studies. However, the mechanisms underlying circadian rhythm-mediated blood pressure regulation and the efficacy of chronotherapy in hypertension remain unclear. This review summarizes the results of the National Heart, Lung, and Blood Institute workshop convened on October 27 to 29, 2021 to assess knowledge gaps and research opportunities in the study of circadian rhythm of blood pressure and chronotherapy for hypertension.
AB - Healthy individuals exhibit blood pressure variation over a 24-hour period with higher blood pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of the blood pressure circadian rhythm has been linked to adverse health outcomes, for example, cardiovascular disease, dementia, and chronic kidney disease. However, the current diagnostic and therapeutic approaches lack sufficient attention to the circadian rhythmicity of blood pressure. Sleep patterns, hormone release, eating habits, digestion, body temperature, renal and cardiovascular function, and other important host functions as well as gut microbiota exhibit circadian rhythms, and influence circadian rhythms of blood pressure. Potential benefits of nonpharmacologic interventions such as meal timing, and pharmacologic chronotherapeutic interventions, such as the bedtime administration of antihypertensive medications, have recently been suggested in some studies. However, the mechanisms underlying circadian rhythm-mediated blood pressure regulation and the efficacy of chronotherapy in hypertension remain unclear. This review summarizes the results of the National Heart, Lung, and Blood Institute workshop convened on October 27 to 29, 2021 to assess knowledge gaps and research opportunities in the study of circadian rhythm of blood pressure and chronotherapy for hypertension.
KW - microbiota
KW - vasculature
KW - kidney
KW - circadian clock
KW - sleep
UR - http://www.scopus.com/inward/record.url?scp=85148250655&partnerID=8YFLogxK
U2 - 10.1161/HYPERTENSIONAHA.122.19372
DO - 10.1161/HYPERTENSIONAHA.122.19372
M3 - Review article
C2 - 36448463
SN - 0194-911X
VL - 80
SP - 503
EP - 522
JO - Hypertension
JF - Hypertension
IS - 3
ER -